Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.54 in the latest trading session, marking a +0.85% move from the prior day. The stock outpaced the S&P 500’s daily loss of 0.16%. Meanwhile, the Dow lost 0.12%, and the Nasdaq, a tech-heavy index, lost 0.33%.

Coming into today, shares of the company had gained 6.53% in the past month. In that same time, the Medical sector lost 8.16%, while the S&P 500 lost 10.5%.

TEVA will be looking to display strength as it nears its next earnings release. In that report, analysts expect TEVA to post earnings of $0.58 per share. This would mark a year-over-year decline of 3.33%. Meanwhile, our latest consensus estimate is calling for revenue of $4.13 billion, down 3.84% from the prior-year quarter.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $2.44 per share and revenue of $16.67 billion. These totals would mark changes of +1.67% and -3.97%, respectively, from last year.

Investors might also notice recent changes to analyst estimates for TEVA. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company’s business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.97% lower within the past month. TEVA is holding a Zacks Rank of #3 (Hold) right now.

Looking at its valuation, TEVA is holding a Forward P/E ratio of 3.88. Its industry sports an average Forward P/E of 5.84, so we one might conclude that TEVA is trading at a discount comparatively.

Home of Science
Follow me

Latest posts by Home of Science (see all)
- Advertisement -

Discover

Sponsor

Latest

An oil deal is still ‘tricky,’ prices could dip into the teens if it falls apart: Strategist

KEY POINTS “A lot is still in play, I think it’s still challenging to get a deal across the finish line,” said Helima Croft of...

A Review of Girlfriends by Billie Eilish

Billie Eilish is an excellent actress, and this recent film Girlfriends, with Robert De Niro, is the best film of her career. She seems...

The X-Files – Book Review of “The Road to Skulath” by Travis McElroy

In the third installment of The X-Files, the once reliable nuclear weapons specialist, Khalid, is listed as "missing in action" by the United States...

How to Use a Business Plan Template For Your Needs

When you begin thinking about starting a business or revamping your current one, a business plan template is a must-have. While it may seem...

Oscar – Who Is Oscar and Why Is He Called an Oscar?

Oprah Winfrey has a three-year-old boy. She brought him along to her high school prom and he fell down the stairs. He broke several...
Home of Science
Follow me
Latest posts by Home of Science (see all)